Sio Capital Management, LLC Mirum Pharmaceuticals, Inc. Transaction History

Sio Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$18.42 - $27.5 $2.97 Million - $4.44 Million	-161,285 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$15.5 - $23.93 $1.69 Million - $2.61 Million	-109,029 Reduced 40.33%	161,285 $3.55 Million
Q4 2021 Feb 14, 2022	BUY	$13.05 - $19.35 $278,434 - $412,851	21,336 Added 8.57%	270,314 $4.31 Million
Q3 2021 Nov 15, 2021	SELL	$13.95 - $20.18 $2.87 Million - $4.16 Million	-205,914 Reduced 45.27%	248,978 $4.96 Million
Q2 2021 Aug 16, 2021	BUY	$15.84 - $20.6 $281,223 - $365,732	17,754 Added 4.06%	454,892 $7.87 Million
Q1 2021 May 14, 2021	SELL	$16.29 - $21.92 $938,385 - $1.26 Million	-57,605 Reduced 11.64%	437,138 $8.66 Million
Q4 2020 Feb 16, 2021	BUY	$15.75 - $25.45 $7.79 Million - $12.6 Million	494,743 New	494,743 $8.64 Million
Q2 2020 Aug 14, 2020	SELL	$11.51 - $20.97 $123,168 - $224,399	-10,701 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.38 - $23.79 $100,375 - $254,576	10,701 New	10,701 $150,000

190

54M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.53B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.